Connect

Faculty & Staff Honors

Faculty & Staff Honors

Columbia ICAP Founder Featured in PBS NewsHour Series on AIDS

A dialogue with Dr. Wafaa El-Sadr, founder and director of ICAP, Columbia University Mailman School of Public Health professor of epidemiology and medicine and Dr. Mathilde Krim-amfAR, chair of global health, was featured in the PBS NewsHour special series, “The End of AIDS,” which has received the 2017 Communication Award by the National Academies of Sciences, Engineering, and Medicine. The PBS program explored the stories of HIV/AIDS victims and the creative strategies that communities in the U.S. and Africa are applying to fight the epidemic, and was praised for being “a compelling series that challenges long-held assumptions about the status of AIDS.” Most recently, the program also received a News & Documentary Emmy.


[Photo: Dr. Wafaa El-Sadr]

In addition to the interview with Dr. El-Sadr, the six-part special also included footage of outreach staff from the Harlem Prevention Center, one of two sites in New York City where ICAP research studies are currently underway.

Getting those individuals into care, on treatment, for their own benefit, as well as, of course, to prevent transmission from them to others, that’s something that we have to tackle,” said Dr. El-Sadr in the video. “And that’s usually individuals who are disenfranchised, afraid, in denial, stigmatized. So it’s a hard-to-reach population that we must reach…I think we can do it (break the back of the epidemic)…it can be done. I’m not saying we’re going to go to zero, but I think we can decrease the numbers substantially.”

ICAP was founded by in 2003 at Columbia University Mailman School of Public Health. A global leader in HIV and health systems strengthening, ICAP provides technical assistance and implementation support to governments and non-governmental organizations in more than 21 countries. ICAP has supported work at more than 5,300 health facilities around the world. More than 2.3 million people have received HIV care through ICAP-supported programs and over 1.3 million have begun antiretroviral therapy. Read more